Paysign initiated with a Buy at Lake Street

Lake Street initiated coverage of Paysign (PAYS) with a Buy rating and $6 price target Paysign is a “market leader” in prepaid plasma donor incentive programs with 40% market share and two of the top three plasma donation center providers, notes the analyst, who calls this “a long-term growth market” given that there are several use cases for the extracted plasma. The firm “conservatively” estimates new donation center openings can grow at a 5% compound annual growth rate through 2026 with stable market share, equating to mid-single digit revenue growth potential from the plasma segment for Paysign, the analyst added.